ストレプトゾトシン糖尿病ラットにおける血中cAMP濃度, 組織cAMP含量および尿中cAMP排泄量の関係
スポンサーリンク
概要
- 論文の詳細を見る
Relationships between plasma cAMP concentration, cAMP content in various tissues and urinary cAMP excretion were investigated to elucidate cAMP metabolism in streptzotocin-induced diabetic rats. The rats were made diabetic by a single injection of 60mg/kg of streptozotocin into the cervical vein. The plasma cAMP in various blood vessels and cAMP content in various tissues were measured 10 days after the injection of streptozotocin. Urinary cAMP excretion levels were determined 5 days before to 10 days after the streptozotocin injection.<BR>The increase in plasma glucose and IRG and the decrease in plasma IRI were certified in diabetic rats. The plasma cAMP concentration in the cervical vein and abdominal aorta in diabetic rats did not change significantly although their plasma cAMP concentration in the hepatic vein was significantly increased compared with the control rats. Hepatic cAMP content in diabetic rats was higher than that in the control rats, but the cAMP content in the renal cortex in the diabetic rats was significantly lower than that in the control rats. In the diabetic rats, the cAMP content in the brain, myocardium, small intestine and skeletal muscle was not different from that in the control rats.<BR>The urinary cAMP excretion level in the diabetic rats was significantly higher than that in the control rats from the second day to the 10th day after the injection of streptozotocin. The creatinine clearance as well as the cAMP clearance in the diabetic rats was higher than that in the control rats.<BR>In conclusion, in streptozotocin-induced diabetic rats, the plasma cAMP concentration did not increase after the injection of streptozotocin, despite an increase in cAMP content in the liver and plasma cAMP level in the hepatic vein. The increase in urinary cAMP excretion level in the diabetic rats as a result of increased glomerular filtration may be one reason for the failure of plasma cAMP to increase.
- 日本内分泌学会の論文
著者
関連論文
- 22)虚血性心疾患におけるHDL-コレステロールについて : 日本循環器学会第56回東海・第41回北陸合同地方会
- Chlorpropamideによる低ナトリウム血症
- 血清creatine phosphokinase (CPK),ミオグロビンが異常高値を示した糖尿病性ケトアシドーシスの1例
- ストレプトゾトシン糖尿病ラットにおける血中cAMP濃度,組織cAMP含量および尿中cAMP排泄量の関係
- 早朝空腹時血糖値が正常化した糖尿病患者におけるインスリン低血糖時の血漿グルカゴン反応
- グルカゴンレセプタ-とグルカゴン作用 (グルカゴンの生理と臨床--最近の進歩)
- 糖尿病患者の早朝空腹時血漿cAMP
- 糖尿病患者における少量インスリン静注時の心電図変化と血清カリウム,血漿cAMPの変動との関係
- 33.糖尿病患者の温度党閾値について(第792回 千葉医学会例会・第二内科例会)
- 42. 未治療で高血糖を呈したインスリン非依存型糖尿病患者の膵B細胞機能の改善 : 食事負荷時の血清C-ペプチド反応を指標として(第774回 千葉医学会例会・第二内科例会)
- 7.ケトアシドーシスをきたした肥満型NIDDMの二症例 : 治療経過に伴う尿中及び血中C-ペプチドの変動について(第6回千葉糖尿病研究会)
- ストレプトゾトシン糖尿病ラットにおける血中cAMP濃度, 組織cAMP含量および尿中cAMP排泄量の関係
- タイトル無し